Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | BioTech • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management |
Stages | Seed, Startup, Early Stage |
Investing | United States • Canada • Europe |
Investment Range | $7,500,000 - $47,200,000 |
Assets Under Management | $100,000,000 |
MPH is the venture capital arm of Mitsubishi Tanabe Pharma Corporation (MTPC). MPH invests in innovative companies developing novel therapeutics, platform technologies, and vaccines.